Stockholm - Delayed Quote SEK

Ortivus AB (publ) (ORTI-B.ST)

Compare
1.7500 +0.0600 (+3.55%)
At close: 4:42 PM GMT+1
Loading Chart for ORTI-B.ST
DELL
  • Previous Close 1.6900
  • Open 1.6300
  • Bid 1.7200 x --
  • Ask 1.7500 x --
  • Day's Range 1.6300 - 1.7500
  • 52 Week Range 1.4550 - 3.9200
  • Volume 17,150
  • Avg. Volume 9,641
  • Market Cap (intraday) 82.968M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Ortivus AB (publ) develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitors and measures the patient's vital parameters, such as ECG, blood pressure, and blood oxygenation; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed Life, which is designed for advanced monitoring and resuscitation; and MobiMed Cloud that supports multiplatform data sharing on Windows, Webb, IOS, and Android. It also provides support, implementation, training, and consulting services. The company was incorporated in 1985 and is headquartered in Danderyd, Sweden.

www.ortivus.com

41

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ORTI-B.ST

View More

Performance Overview: ORTI-B.ST

Trailing total returns as of 11/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ORTI-B.ST
52.83%
OMX Stockholm 30 Index
3.97%

1-Year Return

ORTI-B.ST
30.56%
OMX Stockholm 30 Index
13.40%

3-Year Return

ORTI-B.ST
68.47%
OMX Stockholm 30 Index
5.08%

5-Year Return

ORTI-B.ST
58.33%
OMX Stockholm 30 Index
42.88%

Compare To: ORTI-B.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ORTI-B.ST

View More

Valuation Measures

Annual
As of 11/18/2024
  • Market Cap

    76.82M

  • Enterprise Value

    112.17M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.96

  • Price/Book (mrq)

    31.45

  • Enterprise Value/Revenue

    1.44

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -22.82%

  • Return on Assets (ttm)

    -13.73%

  • Return on Equity (ttm)

    -156.26%

  • Revenue (ttm)

    77.96M

  • Net Income Avi to Common (ttm)

    -17.79M

  • Diluted EPS (ttm)

    -0.4000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.12M

  • Total Debt/Equity (mrq)

    1,573.67%

  • Levered Free Cash Flow (ttm)

    -2.29M

Research Analysis: ORTI-B.ST

View More

Company Insights: ORTI-B.ST

Research Reports: ORTI-B.ST

View More

People Also Watch